scispace - formally typeset
D

Diego Jose Laderach

Researcher at National University of Luján

Publications -  21
Citations -  698

Diego Jose Laderach is an academic researcher from National University of Luján. The author has contributed to research in topics: Galectin & Tumor microenvironment. The author has an hindex of 14, co-authored 21 publications receiving 591 citations. Previous affiliations of Diego Jose Laderach include National Scientific and Technical Research Council & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

RNA Interference Shows Critical Requirement for NF-κB p50 in the Production of IL-12 by Human Dendritic Cells

TL;DR: RNA interference was used to assess the role of the p50 (NF-κB1) protein in the maturation and activation of cultured human monocyte-derived DC, revealing a pivotal requirement for p50 in MoDC for IL-12 production and induction of optimal type-1 immune responses.
Journal ArticleDOI

Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells.

TL;DR: Extensive Gal1 expression facilitated the transition from epithelial cell morphology towards a fibroblastoid phenotype and favored up‐regulation of the mesenchymal marker vimentin in HCC cells, with critical implications in H CC metastasis.
Journal ArticleDOI

Galectin-8: a matricellular lectin with key roles in angiogenesis.

TL;DR: A novel role for gal-8 is described in the regulation of vascular and lymphatic angiogenesis and evidence of its critical implications in tumor biology is provided, including cell adhesion and migration, which collectively demonstrate the multi-functionality of this complex lectin.
Journal ArticleDOI

Dissecting the signal transduction pathways triggered by galectin–glycan interactions in physiological and pathological settings

TL;DR: Current knowledge on the intracellular signaling pathways triggered by this multifunctional family of β‐galactoside‐binding proteins in selected physiological and pathological settings are discussed.